ESPR

Esperion Therapeutics, Inc.

1 day chart

About ESPR

Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Its NEXLETOL is an ATP Citrate Lyase (ACL), inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. Its NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.

Buy US stocks in Australia starting with ESPR. Open an account and start investing today!

Market Capitalisation

$138.28M

Price-earnings ratio

Dividend yield

0.00%

Volume

1.49K

High today

$1.51

Low today

$1.42

Open price

$0.00

52-week high

$8.87

52-week low

$1.12

ESPR FAQs

Can I buy ESPR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy ESPR shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Esperion Therapeutics, Inc.?

One share of Esperion Therapeutics, Inc. is valued at $1.49.

What is the ticker symbol for Esperion Therapeutics, Inc.?

The ticker symbol for Esperion Therapeutics, Inc. is ESPR.

How do I buy ESPR shares in Australia?

To buy ESPR stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ESPR

What is the 52-week high for Esperion Therapeutics, Inc. stock?

The Esperion Therapeutics, Inc. 52-week high stock price is $8.87.

What is the 52-week low for Esperion Therapeutics, Inc. stock?

The Esperion Therapeutics, Inc. 52-week low stock price is $1.12.

What is the market capitalisation of Esperion Therapeutics, Inc. ESPR?

As of 30/05/2023 Esperion Therapeutics, Inc. has a market cap of $138M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.